The Advisory Council provides a forum for Members to discuss issues affecting the investigator-initiated clinical trials and registries sector and advise the Board on relevant issues and emerging trends, and key strategic objectives for ACTA.
This meeting will also allow us to focus on the recently awarded MRFF grant and ACTA's scope of work to 2024.
We hope that you will be able to join us. Each Full Member and Associate Member is represented on the Advisory Council by a participant appointed by the Member.
As this is a closed meeting, invitations will be distributed by email.
Latest Resources
-
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA submission: Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia
-
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
ACTA Year in Review: Financial Year 2018-2019
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Opportunities for linking evidence development to reimbursement in Australia
-
Clinical Quality Registries: A national approach
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
-
ACTA Summit 2016 – Opening address
-
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
-
ACTA Summit 2016 – Dr Neil Soderlund
-
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
-
ACTA Submission to the NHMRC Structural Review
-
ACTA Submission on the MRFF Strategy & Priorities
-
ACTA Submission on the National Safety and Quality Health Service Standards Version 2: Consultation Draft
-
ACTA Submission to the Medicare Benefits Schedule Review Taskforce
-
ACTA Submission to the Community Affairs Legislation Committee on the Medical Research Future Fund Bill 2015
-
ACTA submission on safety monitoring & reporting of clincial trials in Australia
-
ACTA Submission to The Independent Hospital Pricing Authority (IHPA) Teaching, Training and Research Costing Study
-
ACTA Submission on draft Principles for accessing and using publicly funded data for health research
-
WA Health joins national alliance for better evidence in healthcare
-
ACTA submission on revised table of standard costs for clinical trials
-
Report on the ACTA 2014 National Summit of Clinical Trials Networks
-
ACTA submission to the ACSQHC on variation in healthcare
-
ACTA Submission to the Select Committee on Health
-
ACTA Submission to the NHMRC Statement on Consumer & Community Involvement in Health & Medical Research: Public Consultation
-
ACTA Submission to Senate Inquiry into Australia’s Innovation System
-
Australian clinical trials networks shaping modern medicine: Local doctors recognised among the world’s most influential researchers of our time